Search by Drug Name or NDC

    NDC 42291-0926-90 olmesartan medoxomil-hydrochlorothiazide 25; 40 mg/1; mg/1 Details

    olmesartan medoxomil-hydrochlorothiazide 25; 40 mg/1; mg/1

    olmesartan medoxomil-hydrochlorothiazide is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL.

    Product Information

    NDC 42291-0926
    Product ID 42291-926_030a6eab-af2d-3813-e063-6394a90a7731
    Associated GPIs
    GCN Sequence Number 052835
    GCN Sequence Number Description olmesartan/hydrochlorothiazide TABLET 40 MG-25MG ORAL
    HIC3 A4I
    HIC3 Description ANGIOTENSIN RECEPTOR ANTAG.-THIAZIDE DIURETIC COMB
    GCN 20076
    HICL Sequence Number 025446
    HICL Sequence Number Description OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name olmesartan medoxomil-hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name olmesartan medoxomil-hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 25; 40
    Active Ingredient Units mg/1; mg/1
    Substance Name HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
    Labeler Name AvKARE
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021532
    Listing Certified Through 2024-12-31

    Package

    NDC 42291-0926-90 (42291092690)

    NDC Package Code 42291-926-90
    Billing NDC 42291092690
    Package 90 TABLET, FILM COATED in 1 BOTTLE (42291-926-90)
    Marketing Start Date 2023-07-27
    NDC Exclude Flag N
    Pricing Information N/A